Mr. Guthrie moved to suspend the rules and pass the bill, as amended.
H.R. 8205
119th CongressReportedAccelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026
Sponsored by Mike Quigley (Democrat-IL-5)
Actions
Considered under suspension of the rules.
DEBATE - The House proceeded with forty minutes of debate on H.R. 8205.
At the conclusion of debate, the chair put the question on the motion to suspend the rules. Mr. Guthrie objected to the vote on the grounds that a quorum was not present. Further proceedings on the motion were postponed. The point of no quorum was considered as withdrawn.
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-733.
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-733.
Placed on the Union Calendar, Calendar No. 637.
Committee Consideration and Mark-up Session Held
Ordered to be Reported (Amended) by the Yeas and Nays: 46 - 0.
Subcommittee Consideration and Mark-up Session Held
Forwarded by Subcommittee to Full Committee by Voice Vote.
Introduced in House
Introduced in House
Referred to the House Committee on Energy and Commerce.
Referred to the Subcommittee on Health.
